Application 219209

Type: NDA
Sponsor: VERTEX PHARMS INC

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	JOURNAVX	SUZETRIGINE	TABLET;ORAL	50MG	Yes	Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N219209-001	JOURNAVX	SUZETRIGINE	50MG	TABLET / ORAL		RLD, RS	2025-01-30

Orange Book patents#

Current patent rows page 1 of 1 · 1 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N219209-001	11834441	2040-12-04	U-4125	Drug substance, Drug product	2025-02-20

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 1 matching rows.

Application-product, Exclusivity code, Expiration table
Application-product	Exclusivity code	Expiration
N219209-001	NCE	2030-01-30

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N219209-001	JOURNAVX	50MG	TABLET / ORAL	RLD, RS	2025-01-30	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N219209-001	JOURNAVX	50MG	TABLET / ORAL	RLD, RS	2025-01-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N219209-001	JOURNAVX	50MG	TABLET / ORAL	RLD, RS	2025-01-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N219209-001	JOURNAVX	50MG	TABLET / ORAL	RLD, RS	2025-01-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N219209-001	JOURNAVX	50MG	TABLET / ORAL	RLD, RS	2025-01-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N219209-001	JOURNAVX	50MG	TABLET / ORAL	RLD, RS	2025-01-30	`b8a1b40f171c…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N219209-001	JOURNAVX	50MG	TABLET / ORAL	RLD, RS	2025-01-30	`a50c72e98297…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N219209-001	11834441	2040-12-04	U-4125	Drug substance, Drug product	2025-02-20	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N219209-001	11834441	2040-12-04	U-4125	Drug substance, Drug product	2025-02-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N219209-001	11834441	2040-12-04	U-4125	Drug substance, Drug product	2025-02-20	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N219209-001	11834441	2040-12-04	U-4125	Drug substance, Drug product	2025-02-20	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N219209-001	11834441	2040-12-04	U-4125	Drug substance, Drug product	2025-02-20	`fd3edfee7708…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N219209-001	11834441	2040-12-04	U-4125	Drug substance, Drug product	2025-02-20	`a50c72e98297…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2026-08-18 06:07:40	2026-07	N219209-001	NCE	2030-01-30	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N219209-001	NCE	2030-01-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N219209-001	NCE	2030-01-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N219209-001	NCE	2030-01-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N219209-001	NCE	2030-01-30	`fd3edfee7708…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N219209-001	NCE	2030-01-30	`a50c72e98297…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
JOURNAVX	SUZETRIGINE	Sportpharm LLC	d229cf71-96ec-4206-960b-d56fafc250ac	2026-07-21	Warnings, Adverse reactions	Exact identifier application applno (NDA): 219209 application number: NDA219209
JOURNAVX	SUZETRIGINE	Vertex Pharmaceuticals Incorporated	f0976da4-1d20-4517-945c-b60ed2f41c12	2026-04-13	Warnings, Adverse reactions	Exact identifier application applno (NDA): 219209 application number: NDA219209

Documents#

Document, Submission type, Date table
Document	Submission type	Date
84847	SUPPL	2026-01-28
84830	SUPPL	2026-01-26
81311	ORIG	2025-02-24
80893	ORIG	2025-02-07
80891	ORIG	2025-02-07